Efficacy and safety of inotuzumab ozogamicin as the definitive therapeutic option prior to allogeneic hematopoietic stem cell transplantation for pediatric relapsed/refractory B-cell acute lymphoblastic leukemia. - Hu, Guan-hua; Zuo, Ying-xi; Zhang, Xiao-hui; Wang, Yu; Xu, Lan-ping; Xin-lin, Hou; Cheng, Yi-fei; Xiao-jun, Huang (Leukemia & Lymphoma, 2026)